Ladenburg Thalmann Downgrades Millendo Therapeutics Inc. (MLND) to Neutral
Tweet Send to a Friend
Ladenburg Thalmann analyst Matthew Kaplan downgraded Millendo Therapeutics Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
